Document is current
Any future updates will be listed below
-
Authors
Venturini, Jacopo
Chakraborty, Abhijit
Baysal, Mehmet A.
Tsimberidou, Apostolia M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30 CA016672)
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 16 April 2025
First Online: 19 May 2025
Declarations
:
: Not applicable.
: The authors permit the Journal of Hematology and Oncology to publish this work.
: A.M.T declares grants (for institution) from OBI Pharma USA, Inc., Macrogenics, 7 Hills Pharma, Agenus, the Parker Institute for Cancer Immunotherapy, Tachyon, Tempus, Tvardi, IMMATICS, Novocure, Orionis, AbbVie, Vividion, Anaveon; and has consulting/advisory roles for NEX-I, BrYet, Macrogenics. The remaining authors declare no relevant conflict of interest.
